Theriva Biologics, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Theriva Biologics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Theriva Biologics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$7.89M, a 87% decline year-over-year.
  • Theriva Biologics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$28M, a 24.2% decline year-over-year.
  • Theriva Biologics, Inc. annual Operating Income (Loss) for 2023 was -$21.4M, a 0.7% increase from 2022.
  • Theriva Biologics, Inc. annual Operating Income (Loss) for 2022 was -$21.6M, a 51.2% decline from 2021.
  • Theriva Biologics, Inc. annual Operating Income (Loss) for 2021 was -$14.3M, a 40.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$28M -$7.89M -$3.67M -87% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$24.3M -$8.49M -$2.67M -45.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$21.6M -$5.39M -$214K -4.13% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$21.4M -$6.22M +$1.1M +15.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-25
Q3 2023 -$22.5M -$4.22M +$768K +15.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$23.3M -$5.82M -$794K -15.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$22.5M -$5.18M -$926K -21.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$21.6M -$7.32M -$2.05M -39% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 -$19.5M -$4.99M -$1.71M -52.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$17.8M -$5.03M -$1.83M -57.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$16M -$4.25M -$1.72M -67.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$14.3M -$5.27M -$3.13M -147% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$11.1M -$3.28M -$1.16M -55.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$9.98M -$3.2M -$308K -10.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$9.67M -$2.54M +$491K +16.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$10.2M -$2.13M +$1.08M +33.6% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-16
Q3 2020 -$11.2M -$2.11M +$3.13M +59.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 -$14.4M -$2.89M +$749K +20.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$15.1M -$3.03M +$544K +15.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$15.7M -$3.21M +$47K +1.44% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-04
Q3 2019 -$15.7M -$5.24M -$922K -21.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$14.8M -$3.64M +$1.37M +27.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$16.2M -$3.57M +$1.42M +28.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 -$17.6M -$3.26M +$2.53M +43.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-20
Q3 2018 -$20.1M -$4.32M +$1.52M +26.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-04
Q2 2018 -$21.6M -$5M +$1.47M +22.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$23.1M -$4.99M +$3.16M +38.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$26.3M -$5.79M +$4.42M +43.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-27
Q3 2017 -$30.7M -$5.84M +$3.31M +36.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$34M -$6.48M +$2.84M +30.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$36.8M -$8.15M +$2.43M +23% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 -$39.3M -$10.2M +$1.19M +10.4% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-22
Q3 2016 -$40.4M -$9.16M +$2.49M +21.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-01
Q2 2016 -$42.9M -$9.31M +$419K +4.31% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 -$43.4M -$10.6M -$2.37M -28.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 -$41M -$11.4M -$4.29M -60.4% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-22
Q3 2015 -$36.7M -$11.7M -$6.74M -137% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-01
Q2 2015 -$29.9M -$9.73M -$5.08M -109% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-03
Q1 2015 -$24.9M -$8.21M -$4.37M -114% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 -$20.5M -$7.1M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-02
Q3 2014 -$4.91M -$1.55M -45.9% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 -$4.65M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$3.84M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q3 2013 -$3.37M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q3 2011 -$938K -$205K -28% Jul 1, 2011 Sep 30, 2011 10-Q 2011-11-14
Q2 2011 -$920K -$1.89M -194% Apr 1, 2011 Jun 30, 2011 10-Q 2011-08-15
Q3 2010 -$733K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 $973K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.